PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
1992 | 48 | 03 |

Tytuł artykułu

Spostrzezenia nad mozliwosciami klinicznego zastosowania nowej kombinacji antybiotykow - kolistyny ze spiramycyna

Warianty tytułu

Języki publikacji

PL

Abstrakty

EN
There have been done a wide review on the physico-chemical properties of colistin and its antibacterial activity. The antibiotic of peptide nature is very effective against the majority of gram-negative bacterial cells. Colistin is not absorbed from the alimentary tract and therefore it should be given in case of intestine infections caused by E. coli or Salmonella spp instead of sulfamides or tetracyclines (usually not effective). On the other hand chloramphenicol is not allowed to use because of its side effects. Since spiramycin is effective against gram-positive bacteriac and mycoplasms therefore given together with colistin has a wide spectrum of activity. Besides, spiramycin inhibits the process of intestine colonisation by E. coli and colistin kills these bacteriae. According to the data of literature the effectiveness of the two antibiotics administered together has been confirmed in mycoplasmatic infections of the respiratory tract of chickens complicated by pathogenic strains of E. coli. In the studies performed by the authors there was found a high effectiveness of these antibiotics combination in a perihatching period infections (Belcospira orale — Rhone Merieux), in colibacteriosis of piglets and in secondary infections of influenza in horses (Belcospira injectable — Rhone Merieux).

Wydawca

-

Rocznik

Tom

48

Numer

03

Opis fizyczny

s.104-107,tab.,bibliogr.

Twórcy

autor
  • Akademia Rolnicza w Lublinie,ul.Akademicka 12,20-033 Lublin
autor
autor
autor

Bibliografia

  • 1. Alzieu J. P., Levrier В., Libersa M., Bichet Н. J., Van Gool F., Baylex E., Espinasse J.: Bov. Prac. nr 24, 38, 1980.
  • 2. Arnaud J. P.: Study of the prevention of avian mycoplasmosis caused by Mycoplasma gallisepticum, and superinfections in table poultry by distribution of Belcospira orale at the dose 0.5 g/l or 1 g/l for 3 days at the beginning of growth then on the 18 th day, compared with the distribution of 0.5 g/l of tylosin at the same period. June 1989, Internal Raport Rhône-Merieux, no CLI/JC/09.
  • 3. Beguin J. C.: Activity of spiramycin and colistin against the micro-organisms resposible for respiratory, digestive and articular infections of poultry: Pasteurella, Salmonella, E. coli, Mycoplasma galisepticum and M. synoviae. March 1989. Internal Raport Rhône-Merieux no Microb. J.C.04.
  • 4. Briand Y. M.: La Nouvel. Pres. Med. 6, 3741, 1977.
  • 5. Chalabi N., Semmari M.; Magh. Veterinare 4, 26, 1989.
  • 6. Chamberlain G., Needham P.: J. Urol. 116, 172, 1976.
  • 7. Corbin B., Gledel J.: Recl Med. vet. 157, 797, 1981.
  • 8. Courvalin P., Carlier C.: J. Antimicrob. Chemother. 8, 57, 1981.
  • 9. Garrod L., Lambert H. P., O’Grady F.: Antibiotic and Chemotherapy. Wyd. Churchill Livingstone, New York 1981.
  • 10. Goodwin C. S., Klinger B. N., Drefett S. E.: Brit. J. Exper. Path. 52, 138, 1971.
  • 11. Larsen J. L., Nielsen N. C.: Nord. Vet. Med. 27, 353, 1975.
  • 12. Larsen J. L., Sogaard H.: Nordisk Vet. 9, 33, 1981.
  • 13. Larsen J. L., Molier K., Nielsen L., Pedersen F.: Dansk Veterin. Tidsskr. 69, 615, 1986.
  • 14. Renault L., Roux J. K., Berson P., Ferrando R.: Recl Med. Vet. 148, 1251, 1979.
  • 15. Roliński Z., Grzechnik R., Wernicka R.: Medycyna Wet. 43, 412, 1987.
  • 16. Roliński Z., Mazurkiewicz M., Duda M.: Medycyna Wet. 47, 1991 w druku.
  • 17. Wernicki A., Rzedzicki J.: Medycyna Wet. 44, 85, 1988.
  • 18. Ziv G., Wanner M., Nicolet J.: J. Vet. Pharm. Therap. 3, 87, 1980.
  • 19. Ziv G., Nouws J. F. M., Ginneken C. A. M.: J. vet. Pharm. Therap. 5, 45, 1982.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-article-34302365-ccb7-43bc-b1df-0fab5587cf1c
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.